Successful treatment of anorexia with a combination of high-dose olanzapine, fluoxetine and mirtazapine.
Fountoulakis
K N
KN
Iacovides
A
A
Siamouli
M
M
Koumaris
V
V
Kaprinis
G S
GS
D000328:Adult; D000855:Anorexia / Q000188:drug therapy*; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D008803:Mianserin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine; D000077152:Olanzapine; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D005473:Fluoxetine; D008803:Mianserin; D000078785:Mirtazapine; D000077152:Olanzapine; D017367:Selective Serotonin Reuptake Inhibitors